Results 11 to 20 of about 1,968,688 (264)
Immunoglobulin M-degrading enzyme of Streptococcus suis (IdeSsuis) impairs porcine B cell signaling
Streptococcus suis (S. suis) is an important porcine pathogen, causing severe disease like meningitis and septicemia primarily in piglets. Previous work showed that the IgM-degrading enzyme of S.
Annika Katharina Breitfelder +6 more
doaj +1 more source
Regulation of cell adhesion to galectins by glycosylation: A new concept in lymphoma cell adhesion
To investigate the biological roles of glycosylation in human lymphoma cell adhesion to galectins, I performed the cell adhesion assay using neuraminidase or glycosylation inhibitors on B cell lymphoma cell line.
Osamu Suzuki
doaj +1 more source
Human germinal center (GC)-associated lymphoma (HGAL) is a multi-domain adaptor protein expressed in GC B lymphocytes, T follicular helper (Tfh) cells and lymphomas derived from these cells.
Xiaoyu Jiang, Izidore S. Lossos
doaj +1 more source
Revising B Cell Receptors [PDF]
B cell development is often portrayed as a series of decision points that expand an antigen-reactive cell to a clone producing a single antibody. This is hardly the case: B cell development is dependent on a series of error-prone, random rearrangement events that through ongoing ...
D, Nemazee, M, Weigert
openaire +2 more sources
B cell receptor signatures associated with strong and poor SARS-CoV-2 vaccine responses
Breakthrough infection of SARS-CoV-2 is a serious challenge, as increased infections were documented in fully-vaccinated individuals. Recipients with poor antibody response are highly vulnerable to reinfection, whereas those with strong antibody ...
Ke Lin +28 more
doaj +1 more source
Aberrant B-Cell Activation in Systemic Lupus Erythematosus
Background: B lymphocytes (B cells) are essential in humoral response, and their activation is an important first step for the production of antibodies.
Na Kang +6 more
doaj +1 more source
Targeting of B‐cell receptor signalling in B‐cell malignancies [PDF]
AbstractPharmacological agents that inhibit enzymes of the B‐cell receptor (BCR) pathway are of increasing importance in the treatment of B‐cell malignancies. These include inhibitors of Bruton tyrosine kinase (BTK), phosphatidylinositol 3‐kinase (PI3K), splenic tyrosine kinase and protein kinase Cβ.
M. Jerkeman +5 more
openaire +3 more sources
IgD shapes the pre-immune naïve B cell compartment in humans
B cell maturation and immunoglobulin (Ig) repertoire selection are governed by expression of a functional B cell receptor (BCR). Naïve B cells co-express their BCR as IgM and IgD isotype.
Johannes Dirks +6 more
doaj +1 more source
Anqi Lin,1,* Jianbo Fang,1,* Quan Cheng,2,3 Zaoqu Liu,4 Peng Luo,1 Jian Zhang1 1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China; 2Department of Neurosurgery, Xiangya ...
Lin A +5 more
doaj
The role of B cell antigen receptors in mantle cell lymphoma
Mantle cell lymphoma (MCL) is characterized by an aggressive clinical course and secondary resistance to currently available therapies in most cases.
Michael Fichtner +3 more
doaj +1 more source

